SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-18-000437
Filing Date
2018-01-16
Accepted
2018-01-16 16:30:37
Documents
5
Period of Report
2018-02-15
Effectiveness Date
2018-01-16

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT tenx_def14a.htm DEF 14A 250105
2 IMAGE detach.jpg GRAPHIC 5279
3 IMAGE internet.jpg GRAPHIC 8113
4 IMAGE mail.jpg GRAPHIC 8542
5 IMAGE phone.jpg GRAPHIC 8848
  Complete submission text file 0001654954-18-000437.txt   278218
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34600 | Film No.: 18528895
SIC: 8731 Services-Commercial Physical & Biological Research